After years of training at the highest level, Serena Williams choosing a GLP-1 isn’t taking the “easy” way out—it’s doing what’s best for her body now.

Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site will, too.

Actor Jameela Jamil is calling out the press for inaccurately reporting on what she said about Serena Williams and GLP-1s. Here's what she explained.

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

In addition to weight loss treatments, Ro offers virtual healthcare and prescription treatments from real medical providers, with or without insurance. The telehealth company treats concerns such as ...

Celebrities have access to doctors that most others don’t,” Jameela Jamil flags the risks of GLP-1s like those Serena ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily ...

Tennis star Serena Williams recently attributed her dramatic weight loss to GLP-1 medication but according to “The Good Place ...

A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.

The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...